These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 33991169)
1. Genomic profiling in neuronal dyneinopathies and updated classifications. Dafsari HS; Becker LL; von der Hagen M; Cirak S Am J Med Genet A; 2021 Aug; 185(8):2607-2610. PubMed ID: 33991169 [No Abstract] [Full Text] [Related]
2. A child with congenital short gut associated with DYNC2LI1 ciliopathy. Bryson LJ; Flynn DM; Sabharwal A; Ahmed SF; Kinning E Clin Dysmorphol; 2021 Jan; 30(1):66-68. PubMed ID: 32815859 [No Abstract] [Full Text] [Related]
3. A null variant in PUS3 confirms its involvement in intellectual disability and further delineates the associated neurodevelopmental disease. Abdelrahman HA; Al-Shamsi AM; Ali BR; Al-Gazali L Clin Genet; 2018 Dec; 94(6):586-587. PubMed ID: 30308082 [No Abstract] [Full Text] [Related]
4. CNOT2 haploinsufficiency causes a neurodevelopmental disorder with characteristic facial features. Uehara T; Tsuchihashi T; Yamada M; Suzuki H; Takenouchi T; Kosaki K Am J Med Genet A; 2019 Dec; 179(12):2506-2509. PubMed ID: 31512373 [No Abstract] [Full Text] [Related]
5. De novo duplication on Chromosome 19 observed in nuclear family displaying neurodevelopmental disorders. Sjaarda CP; Kaiser B; McNaughton AJM; Hudson ML; Harris-Lowe L; Lou K; Guerin A; Ayub M; Liu X Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32321736 [TBL] [Abstract][Full Text] [Related]
6. Updating the neurodevelopmental profile of Alazami syndrome: Illustrating the role of developmental assessment in rare genetic disorders. Wojcik MH; Linnea K; Stoler JM; Rappaport L Am J Med Genet A; 2019 Aug; 179(8):1565-1569. PubMed ID: 31074943 [TBL] [Abstract][Full Text] [Related]
7. DNA Methylation Possible Adjunct to Screening for Neurodevelopmental Syndromes: DNA methylation signatures were identified for several neurodevelopmental Mendelian disorders, and hold promise as a supplement to standard procedures for screening and detection of these diseases. Am J Med Genet A; 2018 Apr; 176(4):755-756. PubMed ID: 29575619 [No Abstract] [Full Text] [Related]
8. Expanding the genetic and phenotypic relevance of KCNB1 variants in developmental and epileptic encephalopathies: 27 new patients and overview of the literature. Bar C; Barcia G; Jennesson M; Le Guyader G; Schneider A; Mignot C; Lesca G; Breuillard D; Montomoli M; Keren B; Doummar D; Billette de Villemeur T; Afenjar A; Marey I; Gerard M; Isnard H; Poisson A; Dupont S; Berquin P; Meyer P; Genevieve D; De Saint Martin A; El Chehadeh S; Chelly J; Guët A; Scalais E; Dorison N; Myers CT; Mefford HC; Howell KB; Marini C; Freeman JL; Nica A; Terrone G; Sekhara T; Lebre AS; Odent S; Sadleir LG; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R Hum Mutat; 2020 Jan; 41(1):69-80. PubMed ID: 31513310 [TBL] [Abstract][Full Text] [Related]
9. Expanding the phenotypic spectrum associated with mutations of DYNC1H1. Beecroft SJ; McLean CA; Delatycki MB; Koshy K; Yiu E; Haliloglu G; Orhan D; Lamont PJ; Davis MR; Laing NG; Ravenscroft G Neuromuscul Disord; 2017 Jul; 27(7):607-615. PubMed ID: 28554554 [TBL] [Abstract][Full Text] [Related]
11. The clinical presentation caused by truncating CHD8 variants. Douzgou S; Liang HW; Metcalfe K; Somarathi S; Tischkowitz M; Mohamed W; Kini U; McKee S; Yates L; Bertoli M; Lynch SA; Holder S; ; Banka S Clin Genet; 2019 Jul; 96(1):72-84. PubMed ID: 31001818 [TBL] [Abstract][Full Text] [Related]
12. Targeted sequencing and integrative analysis to prioritize candidate genes in neurodevelopmental disorders. Zhang Y; Wang T; Wang Y; Xia K; Li J; Sun Z Mol Neurobiol; 2021 Aug; 58(8):3863-3873. PubMed ID: 33860439 [TBL] [Abstract][Full Text] [Related]
13. Neurodevelopmental assessments of rare genetic conditions. Gada S Dev Med Child Neurol; 2020 Aug; 62(8):894. PubMed ID: 31925785 [No Abstract] [Full Text] [Related]
14. Genomic Aberrations Associated with the Pathophysiological Mechanisms of Neurodevelopmental Disorders. Yamamoto T Cells; 2021 Sep; 10(9):. PubMed ID: 34571966 [TBL] [Abstract][Full Text] [Related]
15. Novel mutations in the DYNC1H1 tail domain refine the genetic and clinical spectrum of dyneinopathies. Peeters K; Bervoets S; Chamova T; Litvinenko I; De Vriendt E; Bichev S; Kancheva D; Mitev V; Kennerson M; Timmerman V; De Jonghe P; Tournev I; MacMillan J; Jordanova A Hum Mutat; 2015 Mar; 36(3):287-91. PubMed ID: 25512093 [TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental and immunological features in a child presenting 22q13.2 microdeletion. Thümmler S; Giuliano F; Karmous-Benailly H; Richelme C; Fernandez A; De Georges C; Askenazy F Am J Med Genet A; 2016 Mar; 170(3):792-4. PubMed ID: 26566763 [No Abstract] [Full Text] [Related]
17. The frontiers of sequencing in undiagnosed neurodevelopmental diseases. Lee H; Nelson SF Curr Opin Genet Dev; 2020 Dec; 65():76-83. PubMed ID: 32599523 [TBL] [Abstract][Full Text] [Related]
18. The clinical-phenotype continuum in DYNC1H1-related disorders-genomic profiling and proposal for a novel classification. Becker LL; Dafsari HS; Schallner J; Abdin D; Seifert M; Petit F; Smol T; Bok L; Rodan L; Krapels I; Spranger S; Weschke B; Johnson K; Straub V; Kaindl AM; Di Donato N; von der Hagen M; Cirak S J Hum Genet; 2020 Nov; 65(11):1003-1017. PubMed ID: 32788638 [TBL] [Abstract][Full Text] [Related]
19. Functional annotation of genomic variation: DNA methylation episignatures in neurodevelopmental Mendelian disorders. Sadikovic B; Levy MA; Aref-Eshghi E Hum Mol Genet; 2020 Sep; 29(R1):R27-R32. PubMed ID: 32644126 [TBL] [Abstract][Full Text] [Related]
20. Target resequencing of neuromuscular disease-related genes using next-generation sequencing for patients with undiagnosed early-onset neuromuscular disorders. Kitamura Y; Kondo E; Urano M; Aoki R; Saito K J Hum Genet; 2016 Nov; 61(11):931-942. PubMed ID: 27357428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]